Wednesday, July 24, 2024 1:00 p.m.–2:00 p.m. ET This year, the federal government has made significant changes to longstanding health care privacy rules, while state lawmakers continue to enact privacy restrictions on consumer health data. These reforms modify legal obligations for providers, payers, and health tech companies, and reflect federal and state governments’ increasing concern […]
Now, more than ever, health care organizations are facing complex antitrust issues as their mergers/acquisitions, hiring, contracting and private funding are being scrutinized by the federal and state governments. Proper planning for any competitive initiative, including day-to-day decisions, is essential to avoid potential antitrust risks. In just the last week, enforcers have announced that they […]
Artificial intelligence (AI) continues to proliferate throughout the health care industry. With each advance comes complex legal and policy questions. Join us for a live webinar to explore these questions—specifically focusing on AI’s impact on payers and providers. Key topics include: Legal and ethical concerns raised by the use of AI, such as errors, bias, […]
From the end of the COVID-19 public health emergency (PHE) to the overturning of Roe v. Wade to the growth of AI in healthcare, multiple forces are converging to remap the health care landscape. In a new webinar, Manatt Health will draw on the deep-dive legal, policy and market analyses in its Manatt on Health premium information […]
The use of augmented intelligence (AI) in medicine has been increasingly used to develop cancer prognoses, respond to patient messages, predict adverse clinical events and recommend optimal staffing volumes in radiology, cardiology and neurology. Join the American Medical Association (AMA) and Manatt Health on May 1 for a live webinar discussion on how the advancement […]
Several states are considering or have enacted legislation to create prescription drug affordability boards (PDABs). Although their powers vary by state, PDABs are generally charged with assessing the affordability of prescription drugs and developing recommendations to reduce spending; negotiating Medicaid supplemental rebates with manufacturers; and/or setting upper payment limits (UPLs), which seek to limit the […]
Three years after the No Surprises Act (NSA) was enacted, industry stakeholders and government regulators alike are still navigating the intricate twists and turns of the wide-ranging legislation’s key provisions. In a new webinar, Manatt Health will explain the major developments impacting NSA and share critical insights into their implications for your organization. The CLE-eligible […]
In the United States, public health and health care delivery have largely taken different and siloed approaches, with health care focused on the treatment of individuals and public health centered on the total population within a geographic region. As interventions that address health-related social needs to improve outcomes have become more prevalent, however, a strong […]
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans and insurers to offer mental health coverage in “parity” with a plan’s medical or surgical coverage. In 2024, as the post-COVID era brings a national reckoning with mental health issues, mental health parity has risen to the forefront of federal and state regulatory […]
Medicaid’s role in addressing housing insecurity and homelessness is rapidly evolving, with many states taking advantage of new federal flexibilities to provide housing and housing-related services to enrollees whose health outcomes depend on being stably housed. Implementing these services, however, is complex and requires collaboration and problem solving that cuts across the health and housing […]
